FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Fdc Timolol Maleate Ophthalmic Solution Recall

Timolol Maleate Ophthalmic Solution, USP, 0

FDC Limited · Aurangabad, Maharashtra State, N/A

Risk level
Class II
Reported by FDA
May 15, 2024
Recall ID
D-0488-2024
Check your lot numberHow we source this data

Summary

Fdc recalled Timolol Maleate Ophthalmic Solution starting Apr 25, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0488-2024 on May 15, 2024. Reason: Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers. Status: Terminated.

Why it was recalled

Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.

Product description

Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ

Lot numbers, UPCs & expiration codes

Lot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025.

Where it was sold

New Jersey Only

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0488-2024
Classification
Class II
Status
Terminated
Recall initiated
Apr 25, 2024
FDA report date
May 15, 2024
Quantity
382,104 units
Recall type
Voluntary: Firm initiated
Recalling firm
FDC Limited

Original FDA data

Every field from FDA enforcement report D-0488-2024, exactly as published.

Show all FDA fields
City
Aurangabad, Maharashtra State
Status
Terminated
Country
India
Event ID
94466
Address
B-8 MIDC Industrial Area
Address (line 2)
Waluj District
Code information
Lot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025.
Report date
May 15, 2024
Product type
Drugs
Recall number
D-0488-2024
Classification
Class II
Recalling firm
FDC Limited
Product quantity
382,104 units
Termination date
May 21, 2026
Reason for recall
Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ
Distribution pattern
New Jersey Only
Recall initiation date
Apr 25, 2024
Initial firm notification
Letter
Center classification date
May 7, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0488-2024, published May 15, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls